Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTDSP1 | Q9GZU7 | 4/20 | 0.47 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.47 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 10/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 10/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 10/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 10/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 10/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxapium SCHEMBL1316687 | 0.99 | CTDSP1 (0.49) | CTDSP1PABPC1APOBEC3AAPOBEC3GKMT2A | |
| SCHEMBL27721335 | 0.79 | GRIN1 (0.44) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL11259848 | 0.75 | HTR1A (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Hydrochloric Acid SCHEMBL29449197 | 0.74 | HTR1A (0.48) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL14039627 | 0.72 | CHRM2 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL10807843 | 0.72 | GAA (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL10807846 | 0.70 | CHRM2 (0.39) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL19420724 | 0.66 | CTDSP1 (0.97) | CTDSP1PABPC1APOBEC3AAPOBEC3GKMT2A | |
| SCHEMBL19420729 | 0.66 | CTDSP1 (0.97) | CTDSP1PABPC1APOBEC3AAPOBEC3GKMT2A | |
| SCHEMBL28274789 | 0.63 | CYP3A4 (0.38) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 681 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119630804-A | Batch process for enzymatic modification of lipids | 邦吉SA公司 | 2025-03-14 | — | — | CN | claimed |
| CN-118806672-A | Sleeping mask and preparation method thereof | 上海珈制化妆品有限公司 | 2024-10-22 | — | — | CN | claimed |
| US-20240229089-A1 | A process for enzymatic synthesis of amides from amines and carboxylic acids or esters | XP CHEMISTRIES AB (SE) | 2024-07-11 | — | — | US | claimed |
| EP-4308714-A1 | A PROCESS FOR ENZYMATIC SYNTHESIS OF AMIDES FROM AMINES AND CARBOXYLIC ACIDS OR ESTERS | XP Chemistries AB (SE) | 2024-01-24 | — | — | EP | claimed |
| CN-117305391-A | Method for regulating molecular weight of dextran by enzymolysis | 广西民族大学 | 2023-12-29 | — | — | CN | claimed |
| CN-116490160-A | A mixture containing 1, 2-alkanediol | 西姆莱斯股份公司 | 2023-07-25 | — | — | CN | claimed |
| WO-2022229314-A1 | A PROCESS FOR ENZYMATIC SYNTHESIS OF AMIDES FROM AMINES AND CARBOXYLIC ACIDS OR ESTERS | XP CHEMISTRIES AB (SE) | 2022-11-03 | — | — | WO | claimed |
| EP-4077697-A1 | CARBOXYLIC ACID ESTERS OF XYLITOL AND PROCESS FOR ENZYMATICALLY PREPARING SAME | Evonik Operations GmbH (DE) | 2022-10-26 | — | — | EP | claimed |
| EP-4077696-A1 | PROCESS FOR ENZYMATICALLY PREPARING SUGAR ESTERS AND/OR SUGAR ALCOHOL ESTERS | Evonik Operations GmbH (DE) | 2022-10-26 | — | — | EP | claimed |
| EP-4077698-A1 | SORBITAN ESTERS AND PROCESS FOR ENZYMATICALLY PREPARING SAME | Evonik Operations GmbH (DE) | 2022-10-26 | — | — | EP | claimed |
| CN-101121708-B | Method for synthesizing oxapium iodide and analogue thereof | XIAOXIANG LI | 2010-12-15 | — | — | CN | claimed |
| EP-1879578-A4 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV PHARMACEUTICAL INC (US) | 2009-05-13 | — | — | EP | claimed |
| CN-101121708-A | Method for synthesizing oxapium iodide and analogue thereof | XIAOXIANG LI (CN) | 2008-02-13 | — | — | CN | claimed |
| EP-1879578-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV Pharmaceutical Inc. (US) | 2008-01-23 | — | — | EP | claimed |
| WO-2006102029-A9 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV PHARMACEUTICAL INC (US) | 2006-12-07 | — | — | WO | claimed |
| WO-2006102029-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE | DOV PHARMACEUTICAL, INC. (US) | 2006-09-28 | — | — | WO | claimed |
| WO-2006075908-A1 | WATER TREATMENT DEVICE WHICH DEACTIVATES ELECTROMAGNETIC RADIATION | DEL TORO PADILLA BEATRIZ ANGEL (MX) | 2006-07-20 | — | — | WO | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |